Litoxetine

CAS No. 86811-09-8

Litoxetine( —— )

Catalog No. M36110 CAS No. 86811-09-8

Litoxetine is a selective 5-HT uptake inhibitor and is a 5-HT3 receptor antagonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 149 Get Quote
5MG 218 Get Quote
10MG 326 Get Quote
25MG 539 Get Quote
50MG 771 Get Quote
100MG 1044 Get Quote
500MG 2088 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Litoxetine
  • Note
    Research use only, not for human use.
  • Brief Description
    Litoxetine is a selective 5-HT uptake inhibitor and is a 5-HT3 receptor antagonist.
  • Description
    Litoxetine (SL 81.0385) is a selective 5-HT uptake inhibitor. Litoxetine is a 5-HT3 receptor antagonist with a Ki of 85 nM for cerebral 5-HT3 receptors. Litoxetine is an antidepressant and has antiemetic properties.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    5-HT Receptor
  • Recptor
    5-HT Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    86811-09-8
  • Formula Weight
    241.33
  • Molecular Formula
    C16H19NO
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(OC1CCNCC1)C2=CC3=C(C=C2)C=CC=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. I Angel, et al. Litoxetine: a selective 5-HT uptake inhibitor with concomitant 5-HT3 receptor antagonist and antiemetic properties. Eur J Pharmacol. 1993 Mar 2;232(2-3):139-45.?
molnova catalog
related products
  • Rizatriptan

    Rizatriptan (Risatriptan) is a selective 5-hydroxytryptamine 1B/1D receptor agonist used in the study of migraine.

  • Lesopitron

    Lesopitron is an anxiolytic with pre- and postsynaptic 5-HT1A agonist activity and is more effective than 5-HT1A agonists in rat social interaction and marmoset anxiety models.

  • Nelotanserin

    A potent, selective 5-HT2A inverse agonist with pKi of 9.2; displays >30- and 5000-fold selectivity compared with 5-HT2C and 5-HT2B receptors.